[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"subacute-and-chronic-eczematous-dermatitis-volunteers\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:subacute-and-chronic-eczematous-dermatitis-volunteers":26},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":27,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":30,"lastUpdatePostDateStruct":31,"startDateStruct":34,"completionDateStruct":36,"leadSponsor":38,"locationsCount":4},"100659724","efficacy-and-safety-of-cream-containing-fig-extract-in-subacute-and-chronic-eczematous-dermatitis-volunteers-100659724",false,"NCT07867249","Efficacy and Safety of Cream Containing Fig Extract in Subacute and Chronic Eczematous Dermatitis Volunteers","Efficacy and s","Inclusion Criteria:\n\n* Male or female participants aged 18 years or older.\n* Have subacute or chronic eczematous dermatitis greater than 6.25 cm²\n* Have SCORAD Index score of less than 50, indicating mild to moderate dermatitis.\n* Able to read and write.\n\nExclusion Criteria:\n\n* Allergic to fig extract\n* Have dermatitis on face, genital area, palms, or soles.\n* Used topical medications for itching or oral corticosteroids within 2 weeks\n* Ppregnant or breastfeeding\n* Participating in other clinical research studies","ALL","18 Years",{"count":19,"type":20},20,"ESTIMATED","INTERVENTIONAL",[23],"NA","This study aims to evaluate the efficacy and safety of a cream containing fig extract in volunteers with subacute and chronic eczematous dermatitis. The affected area of subacute and chronic eczematous dermatitis in each participant will be equally divided into two sections (left and right) using block randomization. One section (Area A) will receive the fig extract cream, while the other section (Area B) will receive a placebo cream as the control. All study assessments, including clinical assessments, skin parameter measurements, patient-reported outcomes, and adverse event assessments, will be performed at baseline and at 1, 2, and 3 weeks after treatment initiation.",[26],"Subacute and Chronic Eczematous Dermatitis Volunteers",[28],"dermatitis","NOT_YET_RECRUITING","2026-10-05",{"date":32,"type":33},"2026-10-09","ACTUAL",{"date":35,"type":20},"2026-10-01",{"date":37,"type":20},"2027-05-31",{"name":39,"class":40},"Chulalongkorn University","OTHER"]